Mahmoud El-Tamer, MD

Memorial Sloan Kettering medical oncologist Pedram Razavi specializes in caring for people with breast cancer. His research focus is on cancer genomics.

Mark E. Robson, MD is a distinguished Breast Medical Oncologist & Clinical Geneticist based in New York, NY. Specializing in identifying and managing individuals with an inherited risk for cancer, Dr. Robson focuses on incorporating genetic information into personalized treatment plans. His expertise extends to developing preventive strategies for high-risk individuals and optimizing outcomes for those with hereditary cancers. Dr. Robson's practice places a significant emphasis on the care of young women with breast cancer, particularly those with hereditary forms. Actively involved in advancing treatment options such as PARP inhibitors for this specific patient population, he strives to enhance therapeutic approaches. Additionally, he oversees specialized screening programs for women carrying mutations in BRCA1 or BRCA2. As Chief of the Breast Medicine Service, Dr. Robson brings a wealth of experience in breast cancer management. Noteworthy for his work in genetic risk assessment and personalized treatments, he is recognized for his commitment to improving outcomes for patients with breast cancers and hereditary conditions. Dr. Robson's dedication to bridging genetics and oncology underscores his pivotal role in patient care and research at Mark E. Robson, MD. Generated from the website content

Memorial Sloan Kettering surgeon Hiram Cody specializes in treating breast cancer. He specializes in using sentinel lymph node biopsy to check for the presence of cancer and help patients avoid extensive lymph node removal procedures...